Wave Life Sciences (WVE) Emerges as Obesity Treatment Contender, Oppenheimer Boosts Price Target

Wave Life Sciences Ltd. (NASDAQ:WVE) ranks among the best stocks under $25 to buy now. On December 16, Oppenheimer boosted its price target for Wave Life Sciences Ltd. (NASDAQ:WVE) to $32 from $24, maintaining an Outperform rating on the company’s shares. The firm reported “highly encouraging” interim results for WVE-007, emphasizing the treatment’s clean risk profile at doses up to 600mg and apparent ease of translation from human genetics and preclinical research to clinical outcomes. According to Wave ...